Kalb Michael Wayne

Catalyst Pharmaceuticals, Inc. · Executive Vice President & CFO

Kalb Michael Wayne is listed in public filings as officer: Executive Vice President & CFO. This Kalb Michael Wayne insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Catalyst Pharmaceuticals, Inc. (CPRX). Investors use Kalb Michael Wayne's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Catalyst Pharmaceuticals, Inc.CPRX--13.7k sharesGrant / ExerciseJan 5, 2026Disclosure amount unavailable2.1k shares----
Catalyst Pharmaceuticals, Inc.CPRX--15.7k sharesGrant / ExerciseJan 5, 2026Disclosure amount unavailable7.1k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Catalyst Pharmaceuticals, Inc.CPRX--8.6k sharesGrant / ExerciseNov 21, 2025Disclosure amount unavailable2.5k shares----
Catalyst Pharmaceuticals, Inc.CPRX--11.1k sharesGrant / ExerciseNov 21, 2025Disclosure amount unavailable6.9k shares----
Catalyst Pharmaceuticals, Inc.CPRX$14M607.2k sharesGrant / ExerciseNov 20, 2025$3.0M131.5k shares$22.77--
Catalyst Pharmaceuticals, Inc.CPRX--646.9k sharesGrant / ExerciseNov 20, 2025Disclosure amount unavailable39.7k shares----
Catalyst Pharmaceuticals, Inc.CPRX--4.2k sharesGrant / ExerciseJan 2, 2025Disclosure amount unavailable2.9k shares----
Catalyst Pharmaceuticals, Inc.CPRX--7.1k sharesGrant / ExerciseJan 2, 2025Disclosure amount unavailable7.1k shares----
Catalyst Pharmaceuticals, Inc.CPRX$9.8M462.2k sharesGrant / ExerciseNov 21, 2024$3.6M169.2k shares$21.12--
Catalyst Pharmaceuticals, Inc.CPRX--482.8k sharesGrant / ExerciseNov 21, 2024Disclosure amount unavailable20.7k shares----